| # | % | |||||
|---|---|---|---|---|---|---|
| 351 | RELYPSA INC | 17,200 | 318,000 | 0.02% | Call | |
| 352 | NOVARTIS A G | 3,645 | 301,000 | 0.02% | ||
| 353 | SAGE THERAPEUTICS INC | 10,000 | 301,000 | 0.02% | Call | |
| 354 | TROVAGENE INC | 65,610 | 297,000 | 0.02% | ||
| 355 | ABBOTT LABS | 7,528 | 296,000 | 0.02% | ||
| 356 | BUILDERS FIRSTSOURCE | 26,286 | 296,000 | 0.02% | ||
| 357 | INSYS THERAPEUTICS INC NEW COM NEW | 21,510 | 278,000 | 0.02% | ||
| 358 | CARDIOVASCULAR SYS INC DEL COM | 14,580 | 268,000 | 0.02% | ||
| 359 | THERAPEUTICSMD INC | 31,347 | 266,000 | 0.02% | ||
| 360 | HMS HOLDINGS CORPORATION | 15,000 | 264,000 | 0.02% | Call | |
| 361 | NRG ENERGY INC | 17,615 | 264,000 | 0.02% | ||
| 362 | MAZOR ROBOTICS LTD | 14,580 | 262,000 | 0.02% | ||
| 363 | INTERCEPT PHARMACEUTICALS INCORPORATED | 1,823 | 260,000 | 0.02% | ||
| 364 | Wright Medical Group NV | 14,580 | 253,000 | 0.02% | ||
| 365 | REALOGY HLDGS CORP | 8,515 | 247,000 | 0.02% | ||
| 366 | QIAGEN NV | 10,935 | 238,000 | 0.02% | ||
| 367 | BELLICUM PHARMACEUTICALS INCORPORATED | 18,225 | 236,000 | 0.02% | ||
| 368 | FCB Financial Holdings Inc | 29,400 | 232,000 | 0.02% | ||
| 369 | NEUROCRINE BIOSCIE COM USD0.001 | 5,000 | 227,000 | 0.02% | Put | |
| 370 | STAAR Surgical Co | 40,095 | 221,000 | 0.02% | ||
| 371 | OCERA THERAPEUTICS INC | 112,995 | 215,000 | 0.02% | ||
| 372 | MOLINA HEALTHCARE INC | 4,130 | 206,000 | 0.02% | ||
| 373 | SPECTRANETICS CORP | 10,935 | 205,000 | 0.02% | ||
| 374 | ALNYLAM PHARMACEUTICALS INC | 3,645 | 202,000 | 0.02% | ||
| 375 | Curis, Inc | 126,846 | 198,000 | 0.02% | ||
| 376 | FLUIDIGM CORP DEL COM | 21,870 | 197,000 | 0.02% | ||
| 377 | XENON PHARMACEUTICALS INC | 32,400 | 191,000 | 0.01% | ||
| 378 | SANGAMO THERAPEUTICS INCORPORATED | 32,805 | 190,000 | 0.01% | ||
| 379 | ANTHERA PHARMACEUTICALS I | 60,143 | 186,000 | 0.01% | ||
| 380 | TG THERAPEUTICS INC COM | 30,600 | 185,000 | 0.01% | ||
| 381 | SANOFI SPOND FUNSPONSORED ADR | 32,805 | 177,000 | 0.01% | ||
| 382 | IMMUNOMEDICS INCORPORATED | 72,900 | 169,000 | 0.01% | ||
| 383 | ONCONOVA THERAPEUTICS INC | 26,587 | 154,000 | 0.01% | ||
| 384 | NOVADAQ TECHNOLOGIES INC | 14,580 | 143,000 | 0.01% | ||
| 385 | EXELIXIS INC | 18,225 | 142,000 | 0.01% | ||
| 386 | PACIFIC BIOSCIENCES CALIF IN | 20,000 | 141,000 | 0.01% | Call | |
| 387 | EXACT SCIENCES CORP | 10,935 | 134,000 | 0.01% | ||
| 388 | CYTOKINETICS INC | 13,122 | 125,000 | 0.01% | ||
| 389 | T2 BIOSYSTEMS INCORPORATED | 14,580 | 115,000 | 0.01% | ||
| 390 | ALIMERA SCIENCES INC | 87,480 | 108,000 | 0.01% | ||
| 391 | GERON CORP | 20,700 | 55,000 | 0.00% | ||
| 392 | CATALYST PHARMACEUTICALS INC | 69,255 | 49,000 | 0.00% | ||
| 393 | GOLDEN OCEAN GRP LTD | 68,944 | 46,000 | 0.00% | ||
| 394 | ROKA BIOSCIENCE INC | 54,675 | 31,000 | 0.00% | ||
| 395 | SUNSHINE HEART INC | 29,160 | 13,000 | 0.00% | ||
| 396 | Sunesis Pharmaceuticals I | 21,870 | 12,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001062574-16-000016, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
